Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Moderna Inc has a consensus price target of $143.41 based on the ratings of 25 analysts. The high is $304 issued by Wolfe Research on November 9, 2021. The low is $80 issued by Deutsche Bank on August 6, 2024. The 3 most-recent analyst ratings were released by JP Morgan, Deutsche Bank, and RBC Capital on August 15, 2024, August 6, 2024, and August 5, 2024, respectively. With an average price target of $86 between JP Morgan, Deutsche Bank, and RBC Capital, there's an implied 4.24% upside for Moderna Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Moderna (NASDAQ:MRNA) was reported by JP Morgan on August 15, 2024. The analyst firm set a price target for $88.00 expecting MRNA to rise to within 12 months (a possible 6.67% upside). 36 analyst firms have reported ratings in the last year.
The latest analyst rating for Moderna (NASDAQ:MRNA) was provided by JP Morgan, and Moderna maintained their neutral rating.
The last upgrade for Moderna Inc happened on August 6, 2024 when Deutsche Bank raised their price target to $80. Deutsche Bank previously had a sell for Moderna Inc.
The last downgrade for Moderna Inc happened on August 5, 2024 when RBC Capital changed their price target from $125 to $90 for Moderna Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Moderna, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Moderna was filed on August 15, 2024 so you should expect the next rating to be made available sometime around August 15, 2025.
While ratings are subjective and will change, the latest Moderna (MRNA) rating was a maintained with a price target of $96.00 to $88.00. The current price Moderna (MRNA) is trading at is $82.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.